Gilead Sciences

Yahoo Finance • 14 days ago

Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026

Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on Gilead to $151 from $147 with an Overweight rating on the shares. The firm informed investor... Full story

Yahoo Finance • 15 days ago

Stocks Fall Slightly in Thin Holiday Trade

The S&P 500 Index ($SPX) (SPY) on Tuesday closed down -0.14%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.20%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.25%.  March E-mini S&P futures (ESH26) fell -0.14%, and M... Full story

Yahoo Finance • 15 days ago

Stocks Slip as Bond Yields Rise

The S&P 500 Index ($SPX) (SPY) today is down -0.12%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.25%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.11%.  March E-mini S&P futures (ESH26) are down -0.11%, and March E-mini N... Full story

Yahoo Finance • 15 days ago

U.S. stocks struggle as tech-led sell-off continues into the year's last days

[Republican Politics and Wall Street] Douglas Rissing Wall Street's major averages seesawed on Tuesday, as U.S. stocks struggle to keep up after back-to-back declines after a technology-driven sell-off. The benchmark S&P 500 (SP500 [http... Full story

Yahoo Finance • 21 days ago

Sector Update: Health Care Stocks Rise Wednesday Afternoon

Health care stocks were rising in recent early Wednesday afternoon trading, with the NYSE Health Car PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 24 days ago

Dow Jones Futures Due; Palantir, GE Lead 12 Stocks In Buy Zones

Bearish conditions on Wednesday turned bullish by Friday's close, with the S&P 500 and Nasdaq back above their 50-day lines. Palantir and GE lead a slew of new buys. Continue Reading... Full story

Yahoo Finance • 26 days ago

Nine Major Drugmakers Agree To Lower Drug Prices Through TrumpRx Initiative

(RTTNews) - President Donald Trump announced nine new agreements with major pharmaceutical companies aimed at lowering prescription drug prices for Americans. The White House said the agreements will ensure that U.S. patients pay prices in... Full story

Yahoo Finance • 26 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as Oracle, Nvidia lead AI trade resurgence

US stocks rose on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street optimism toward the tail end of a topsy-turvy week. The S&P 500 (^GSPC) put on 0.8% and the Nasdaq Comp... Full story

Yahoo Finance • 26 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Health care stocks rose late Friday afternoon, with the NYSE Health Care Index increasing 0.8% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as Nvidia, Oracle shine in tech revival

US stocks rose on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street optimism toward the tail end of a topsy-turvy week. The S&P 500 (^GSPC) put on 0.9%, and the Nasdaq Com... Full story

Yahoo Finance • 26 days ago

Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump

Dow Jones stock Merck struck a Most Favored Nation agreement with the Trump administration on Friday, joining other pharma bellwethers. Continue Reading... Full story

Yahoo Finance • 26 days ago

Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans

Agreement addresses all requests by President Trump to reduce drug costs in the U.S., encourage global investment and protect American biopharma leadership Company reinforces commitment to U.S. manufacturing and American jobs FOSTER CITY... Full story

Yahoo Finance • 26 days ago

Top Midday Stories: Oracle, Others Form JV to Oversee TikTok in US; More Drugmakers to Announce US Drug Price Deals

All three major US stock indexes were up in late-morning trading Friday, as the artificial-intellige PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 29 days ago

Morning Bid: Inflation Grinch Creeps Up On Wall Street 

By Naomi Rovnick LONDON, Dec 17 (Reuters) - By Naomi Rovnick, global markets correspondent. What matters in U.S. and global markets today Wall Street's traditional Santa rally is nowhere to be found as inflation anxiety and geopolitical... Full story

Yahoo Finance • 30 days ago

Alger Russell Innovation Index Updates for Fourth Quarter 2025

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close... Full story

Yahoo Finance • 30 days ago

XLV, AMGN, GILD, MDT: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Health Care Select Sector SPDR ETF (Symbol: XLV) where we have detected an approximate $439.1 mi... Full story

Yahoo Finance • last month

Why Arcus Biosciences Just Reversed Its 287% Eight-Month Winning Streak

Arcus Biosciences stock plunged Friday, reversing a nearly 300% gain, after its Gilead Sciences-partnered cancer regimen failed. Continue Reading... Full story

Yahoo Finance • last month

Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight

ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as Johnson & Johnson, Arcellx, Gilead, Bris... Full story

Yahoo Finance • last month

New Study: Integrative Therapy and Nurse Navigation Reduce Treatment Side Effects for 75% of Black Breast Cancer Patients; 85% Report Lower Distress

Unite for HER and TOUCH, The Black Breast Cancer Alliance Present Pivotal Results for Black Breast Cancer Outcomes at 2025 San Antonio Breast Cancer Symposium ANNAPOLIS, Md. & PHILADELPHIA, December 10, 2025--(BUSINESS WIRE)--Leading brea... Full story

Yahoo Finance • last month

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic field of immuno-oncology, shedding light on c... Full story